ECSP12011843A - Arilindenopirimidinas sustituidas con arilo y su uso como antagonistas de receptores de adenosina a2a altamente selectivos - Google Patents

Arilindenopirimidinas sustituidas con arilo y su uso como antagonistas de receptores de adenosina a2a altamente selectivos

Info

Publication number
ECSP12011843A
ECSP12011843A ECSP12011843A ECSP12011843A EC SP12011843 A ECSP12011843 A EC SP12011843A EC SP12011843 A ECSP12011843 A EC SP12011843A EC SP12011843 A ECSP12011843 A EC SP12011843A
Authority
EC
Ecuador
Prior art keywords
arilindenopirimidinas
arilo
adenosine
antagonists
replaced
Prior art date
Application number
Other languages
English (en)
Inventor
Paul Jackson
Brian Christopher Shook
Mark Powell
Aihua Wang
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ECSP12011843A publication Critical patent/ECSP12011843A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se relaciona con una nueva arilindenopirimidina, A, y sus usos terapéuticos y profilácticos. Los trastornos tratados y/o prevenidos incluyen la enfermedad de Parkinson en donde, X, R2, R3 y R4 son como se definen en la especificación.
ECSP12011843 2009-10-29 2012-04-27 Arilindenopirimidinas sustituidas con arilo y su uso como antagonistas de receptores de adenosina a2a altamente selectivos ECSP12011843A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25593009P 2009-10-29 2009-10-29

Publications (1)

Publication Number Publication Date
ECSP12011843A true ECSP12011843A (es) 2012-06-29

Family

ID=43216987

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12011843 ECSP12011843A (es) 2009-10-29 2012-04-27 Arilindenopirimidinas sustituidas con arilo y su uso como antagonistas de receptores de adenosina a2a altamente selectivos

Country Status (10)

Country Link
US (1) US20110105492A1 (es)
CN (1) CN102596918A (es)
AU (1) AU2010313576A1 (es)
BR (1) BR112012010131A2 (es)
CA (1) CA2779097A1 (es)
EC (1) ECSP12011843A (es)
IL (1) IL219340A0 (es)
MX (1) MX2012005002A (es)
PH (1) PH12012500808A1 (es)
WO (1) WO2011053509A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958328B2 (en) * 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
US20040127510A1 (en) * 2002-04-16 2004-07-01 Heintzelman Geoffrey R. Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
AU2003275430A1 (en) * 2003-10-03 2005-05-19 Ortho-Mcneil Pharmaceutical, Inc. Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist

Also Published As

Publication number Publication date
AU2010313576A1 (en) 2012-05-24
CN102596918A (zh) 2012-07-18
MX2012005002A (es) 2012-06-12
IL219340A0 (en) 2012-06-28
BR112012010131A2 (pt) 2019-09-24
WO2011053509A1 (en) 2011-05-05
CA2779097A1 (en) 2011-05-05
US20110105492A1 (en) 2011-05-05
PH12012500808A1 (en) 2012-11-26

Similar Documents

Publication Publication Date Title
NI201000005A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico.
SV2010003662A (es) Derivados de azetidina y ciclobutano como inhibidores de jak ref. x-19081
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
NI201100084A (es) Antagonistas del receptor de orexina de isonicotinamida.
CR10149A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
CO6321169A2 (es) Metilenaminas de tieno[2,3-d] pirimidina y su uso como antagonistas de receptores de adenosina a2a
UY34278A (es) Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
CR11562A (es) Bis-piridilpiridonas como antagonistas del receptor 1 de la hormona concentradora de melanina
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
CR20110100A (es) Nuevos derivados de sulfamida sustituida
ATE458740T1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
CR20130209A (es) Derivados de carboxamida como antagonistas del receptor muscarinico
CR10603A (es) Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
BRPI0614397A2 (pt) compostos de pirimidina como moduladores de receptor de serotonina
UY31420A1 (es) Arilindenopirimidinas y su uso como antagonistas del receptor a2a de adenosina
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
ECSP12011842A (es) ARILINDENOPIRIMIDINAS SUSTITUIDAS CON ALQUILO Y SU USO COMO ANTAGONISTAS DEL RECEPTOR DE ADENOSINA A2a ALTAMENTE SELECTIVOS
AR069026A1 (es) Arilindenopirimidinas y su uso como antagonistas de los receptores de adenosina a₂a
ECSP12011840A (es) Arilindenopirimidinas sustituidas con heteroarilo y su uso como antagonistas del receptor de adenosina a2a altamente selectivos
CL2008001007A1 (es) Compuestos derivados de furo[2,3-b] piridina, moduladores del receptor canabinoide-1; y su uso para tratar psicosis, deficit de memoria, trastornos cognitivos, entre otras enfermedades.
ECSP12011841A (es) ARILINDENOPIRIMIDINAS SUSTITUIDAS CON HETEROCICLILO Y SU USO COMO ANTAGONISTAS DE LOS RECEPTORES DE ADENOSINA A2a ALTAMENTE SELECTIVOS